Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials

BACKGROUND: Cough and sputum are troublesome symptoms in chronic obstructive pulmonary disease (COPD) and are associated with adverse outcomes. The efficacy of aclidinium bromide 400 µg twice daily in patients with stable COPD has been established in two phase III studies (ACCORD COPD I and ATTAIN)...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:BMJ Open Respir Res
Main Authors: McGarvey, Lorcan, Morice, Alyn H, Smith, Jaclyn A, Birring, Surinder S, Chuecos, Ferran, Seoane, Beatriz, Jarreta, Diana
Formáid: Artigo
Teanga:Inglês
Foilsithe: BMJ Publishing Group 2016
Ábhair:
Chronic Obstructive Pulmonary Disease
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5174811/
https://ncbi.nlm.nih.gov/pubmed/28074135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjresp-2016-000148
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla